Back to 
MACKENZIE FINANCIAL CORP
MACKENZIE FINANCIAL CORP
MYGN2 quarters
Position history for MACKENZIE FINANCIAL CORP's holdings in MYRIAD GENETICS INC
Yes. Mackenzie Financial holds 2,499,354 shares of MYGN (Myriad Genetics), worth $10.8M, as of its Q3 2026 13F filing. It increased the position by 963,652 shares (+62.8%) from Q2 2026. Mackenzie Financial has held MYGN since Q2 2026, across 2 quarterly 13F filings.
Current Value
$10.8M
Current Shares
2.5M
Total Value Change
+$2M
Total Shares Change
+963,652
Quarter-by-Quarter History
Other major holders of MYGN: BlackRock, Inc., BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC